Vilobelimab to improve clinical outcomes in moderate-to-severe hidradenitis suppurativa through an adjunctive effect on draining tunnels: results of the SHINE double-blind placebo-controlled randomized trial.
Saved in:
| Title: | Vilobelimab to improve clinical outcomes in moderate-to-severe hidradenitis suppurativa through an adjunctive effect on draining tunnels: results of the SHINE double-blind placebo-controlled randomized trial. |
|---|---|
| Authors: | Giamarellos-Bourboulis EJ; 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece., Jemec GBE; Department of Dermatology, Zealand University Hospital, Roskilde, Denmark., Prens EP; Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands., Riedemann NC; InflaRx GmbH, Jena, Germany., Otto I; InflaRx GmbH, Jena, Germany., Weisman J; Medical Dermatology Specialists, Sandy Springs, Atlanta, GA, USA., Pulka G; Centrum Medyczne All-Med, Krakòw, Poland., Nowicki RJ; Department of Dermatology, Venereology and Allergology, Medical University of Gdańsk, University Clinical Centre, Gdańsk, Poland., Kantardjiev V; Dermatology and Venereology Department, Military Medical Academy, Sofia, Bulgaria., Pinter A; Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt/Main, Frankfurt/Main, Germany., Thomsen SF; Department of Dermatology, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Copenhagen, Denmark., Berneman D; University of Cincinnati, Department of Dermatology, Cincinnati, OH, USA., Kanni T; 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece., Alavi A; Department of Dermatology, Mayo Clinic Rochester, Rochester, MN, USA., Breno B; CHU Nantes, Hôtel Dieu, Nantes, France., Gooderham M; SKiN Centre for Dermatology, Peterborough, ON, Canada.; Department of Medicine, Queen's University, Kingston, ON, Canada., Stone M; Shenandoah Medical Center, Shenandoah, IA, USA., Anadkat MJ; Department of Medicine, Division of Dermatology, Washington University, St. Louis, MO, USA., Katoulis A; 2nd Department of Dermatology and Venereology, National and Kapodistrian University of Athens, Medical School, Athens, Greece., Papakonstantis M; Department of Dermatology, 401 General Military Hospital of Athens, Athens, Greece., Becherel PA; Department of Dermatology, Antony Private Hospital, Antony, France., Szepietowski JC; Faculty of Medicine, Wrocław University of Science and Technology, Wrocław, Poland.; Department of Dermatovenereology, 4th Military Hospital, Wrocław, Poland., van der Zee HH; Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands., Zouboulis CC; Departments of Dermatology, Venereology, Allergology and Immunology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany., Sayed CJ; Department of Dermatology, University of North Carolina, Chapel Hill, NC, USA. |
| Source: | The British journal of dermatology [Br J Dermatol] 2026 Jan 27; Vol. 194 (2), pp. 254-263. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
